BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3531422)

  • 1. Follicular lymphoma: prognostic factors for response and survival.
    Gallagher CJ; Gregory WM; Jones AE; Stansfeld AG; Richards MA; Dhaliwal HS; Malpas JS; Lister TA
    J Clin Oncol; 1986 Oct; 4(10):1470-80. PubMed ID: 3531422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group.
    Anderson JR; Vose JM; Bierman PJ; Weisenberger DD; Sanger WG; Pierson J; Bast M; Armitage JO
    J Clin Oncol; 1993 Feb; 11(2):218-24. PubMed ID: 8426197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular large cell lymphoma: analysis and prognostic factors in 62 patients.
    Kantarjian HM; McLaughlin P; Fuller LM; Dixon DO; Osborne BM; Cabanillas FF
    J Clin Oncol; 1984 Jul; 2(7):811-9. PubMed ID: 6376721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
    Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
    J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
    Barzenje DA; Cvancarova Småstuen M; Liestøl K; Fosså A; Delabie J; Kolstad A; Holte H
    PLoS One; 2015; 10(7):e0131158. PubMed ID: 26147646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
    J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular large-cell lymphoma: intermediate or low grade?
    Bartlett NL; Rizeq M; Dorfman RF; Halpern J; Horning SJ
    J Clin Oncol; 1994 Jul; 12(7):1349-57. PubMed ID: 8021725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma.
    Besa PC; McLaughlin PW; Cox JD; Fuller LM
    Cancer; 1995 May; 75(9):2361-7. PubMed ID: 7712449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
    Morschhauser F; Radford J; Van Hoof A; Vitolo U; Soubeyran P; Tilly H; Huijgens PC; Kolstad A; d'Amore F; Gonzalez Diaz M; Petrini M; Sebban C; Zinzani PL; van Oers MH; van Putten W; Bischof-Delaloye A; Rohatiner A; Salles G; Kuhlmann J; Hagenbeek A
    J Clin Oncol; 2008 Nov; 26(32):5156-64. PubMed ID: 18854568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
    Decaudin D; Lepage E; Brousse N; Brice P; Harousseau JL; Belhadj K; Tilly H; Michaux L; Chèze S; Coiffier B; Solal-Céligny P
    J Clin Oncol; 1999 Aug; 17(8):2499-505. PubMed ID: 10561315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas.
    Rohatgi N; LaRocca RV; Bard V; Sethuraman G; Foon KA
    Am J Hematol; 2002 Jul; 70(3):181-5. PubMed ID: 12111762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follicle centre lymphoma: treatment results for stage I and II].
    Neumann H; Blanck H; Koch R; Fiedler S; Lesche A; Herrmann T
    Strahlenther Onkol; 2003 Dec; 179(12):840-6. PubMed ID: 14652673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy in advanced stages (III and IV) of follicular lymphoma increases the possibility of cure: results of a large controlled clinical trial.
    Avilés A; Delgado S; Fernández R; Talavera A; Neri N; Huerta-Guzmán J
    Eur J Haematol; 2002 Mar; 68(3):144-9. PubMed ID: 12068794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study.
    Herold M; Haas A; Srock S; Neser S; Al-Ali KH; Neubauer A; Dölken G; Naumann R; Knauf W; Freund M; Rohrberg R; Höffken K; Franke A; Ittel T; Kettner E; Haak U; Mey U; Klinkenstein C; Assmann M; von Grünhagen U;
    J Clin Oncol; 2007 May; 25(15):1986-92. PubMed ID: 17420513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial to evaluate the role of interferon as initial and maintenance therapy in patients with follicular lymphoma.
    Rohatiner A; Radford J; Deakin D; Earl H; Love SB; Price O; Wilson A; Lister TA
    Br J Cancer; 2001 Jul; 85(1):29-35. PubMed ID: 11437398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?
    Mac Manus MP; Rainer Bowie CA; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):365-71. PubMed ID: 9788417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University.
    Mac Manus MP; Hoppe RT
    J Clin Oncol; 1996 Apr; 14(4):1282-90. PubMed ID: 8648385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome and prognostic factors for primary nasal lymphoma.
    Liang R; Todd D; Chan TK; Chiu E; Lie A; Kwong YL; Choy D; Ho FC
    J Clin Oncol; 1995 Mar; 13(3):666-70. PubMed ID: 7884427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.